Internalization and coreceptor expression are critical for TLR2-mediated recognition of lipoteichoic acid in human peripheral blood

Journal of Immunology

Volumn 185, Issue 6, 2010, Pages 3708-3717

  Bunk, Sebastian ^a   Sigel, Stefanie ^a,b   Metzdorf, Daniela ^a   Sharif, Omar ^b   Triantafilou, Kathy ^c   Triantafilou, Martha ^c   Hartung, Thomas ^a,d   Knapp, Sylvia ^b   Von Aulock, Sonja ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF SUSSEX   (United Kingdom)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CYTOKINE; LIPOPROTEIN; LIPOTEICHOIC ACID; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6;

ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; INTERNALIZATION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS;

ADJUVANTS, IMMUNOLOGIC; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS, CD14; CELL LINE; CELL MEMBRANE; CYTOKINES; HUMANS; IMMUNOGLOBULIN G; INTRACELLULAR FLUID; LIPOPOLYSACCHARIDES; LIPOPROTEINS; OPSONIN PROTEINS; RECEPTORS, IGG; STAPHYLOCOCCUS AUREUS; TEICHOIC ACIDS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 6;

EID: 78149468874     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901660     Document Type: Article

References (49)

1. von Eiff, C., K. Becker, K. Machka, H. Stammer, G. Peters; Study Group. 2001. Nasal carriage as a source of Staphylococcus aureus bacteremia. N. Engl. J. Med. 344: 11-16.
2. Todd, J. K. 2005. Staphylococcal infections. Pediatr. Rev. 26: 444-450.
3. Jonsson, I. M., S. K. Mazmanian, O. Schneewind, T. Bremell, and A. Tarkowski. 2003. The role of Staphylococcus aureus sortase A and sortase B in murine arthritis. Microbes Infect. 5: 775-780.
4. Thomas, C. A., Y. Li, T. Kodama, H. Suzuki, S. C. Silverstein, and J. El Khoury. 2000. Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagocytosis. J. Exp. Med. 191: 147-156.
5. Janeway, C. A., Jr., and R. Medzhitov. 2002. Innate immune recognition. Annu. Rev. Immunol. 20: 197-216.
6. Inohara, Chamaillard, C. McDonald, and G. Nuñez. 2005. NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu. Rev. Biochem. 74: 355-383.
7. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801.
8. Hoebe, K., P. Georgel, S. Rutschmann, X. Du, S. Mudd, K. Crozat, S. Sovath, L. Shamel, T. Hartung, U. Zähringer, and B. Beutler. 2005. CD36 is a sensor of diacylglycerides. Nature 433: 523-527.
9. Takeuchi, O., K. Hoshino, and S. Akira. 2000. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165: 5392-5396.
10. Hornung, V., S. Rothenfusser, S. Britsch, A. Krug, B. Jahrsdörfer, T. Giese, S. Endres, and G. Hartmann. 2002. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168: 4531-4537.
11. Seo, H. S., S. M. Michalek, and M. H. Nahm. 2008. Lipoteichoic acid is important in innate immune responses to gram-positive bacteria. Infect. Immun. 76: 206-213.
12. Buwitt-Beckmann, U., H. Heine, K. H. Wiesmüller, G. Jung, R. Brock, and A. J. Ulmer. 2005. Lipopeptide structure determines TLR2 dependent cell activation level. FEBS J. 272: 6354-6364.
13. Dziarski, R., and D. Gupta. 2006. The peptidoglycan recognition proteins (PGRPs). Genome Biol. 7: 232.
14. Travassos, L. H., S. E. Girardin, D. J. Philpott, D. Blanot, M. A. Nahori, C. Werts, and I. G. Boneca. 2004. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep. 5: 1000-1006.
15. Dziarski, R., and D. Gupta. 2005. Staphylococcus aureus peptidoglycan is a toll-like receptor 2 activator: a reevaluation. Infect. Immun. 73: 5212-5216.
16. Jin, M. S., S. E. Kim, J. Y. Heo, M. E. Lee, H. M. Kim, S. G. Paik, H. Lee, and J. O. Lee. 2007. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130: 1071-1082.
17. Kang, J. Y., X. Nan, M. S. Jin, S. J. Youn, Y. H. Ryu, S. Mah, S. H. Han, H. Lee, S. G. Paik, and J. O. Lee. 2009. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 31: 873-884.
18. Ip, W. K., K. Takahashi, K. J. Moore, L. M. Stuart, and R. A. Ezekowitz. 2008. Mannose-binding lectin enhances Toll-like receptors 2 and 6 signaling from the phagosome. J. Exp. Med. 205: 169-181.
19. Jimenez-Dalmaroni, M. J., N. Xiao, A. L. Corper, P. Verdino, G. D. Ainge, D. S. Larsen, G. F. Painter, P. M. Rudd, R. A. Dwek, K. Hoebe, et al. 2009. Soluble CD36 ectodomain binds negatively charged diacylglycerol ligands and acts as a co-receptor for TLR2. PLoS ONE 4: e7411.
20. Stuart, L. M., J. Deng, J. M. Silver, K. Takahashi, A. A. Tseng, E. J. Hennessy, R. A. Ezekowitz, and K. J. Moore. 2005. Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. J. Cell Biol. 170: 477-485.
21. Morath, S., A. Geyer, and T. Hartung. 2001. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J. Exp. Med. 193: 393-397.
22. Morath, S., A. Stadelmaier, A. Geyer, R. R. Schmidt, and T. Hartung. 2002. Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release. J. Exp. Med. 195: 1635-1640.
23. Deininger, S., A. Stadelmaier, S. von Aulock, S. Morath, R. R. Schmidt, and T. Hartung. 2003. Definition of structural prerequisites for lipoteichoic acid-inducible cytokine induction by synthetic derivatives. J. Immunol. 170: 4134-4138.
24. Hashimoto, M., K. Tawaratsumida, H. Kariya, A. Kiyohara, Y. Suda, F. Krikae, T. Kirikae, and F. Götz. 2006. Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J. Immunol. 177: 3162-3169.
25. Hashimoto, M., M. Furuyashiki, R. Kaseya, Y. Fukada, M. Akimaru, K. Aoyama, T. Okuno, T. Tamura, T. Kirikae, F. Kirikae, et al. 2007. Evidence of immunostimulating lipoprotein existing in the natural lipoteichoic acid fraction. Infect. Immun. 75: 1926-1932.
26. Hashimoto, M., K. Tawaratsumida, H. Kariya, K. Aoyama, T. Tamura, and Y. Suda. 2006. Lipoprotein is a predominant Toll-like receptor 2 ligand in Staphylococcus aureus cell wall components. Int. Immunol. 18: 355-362.
27. Hashimoto, M., M. Furuyashiki, and Y. Suda. 2007. Response to Comment on "Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus" J. Immunol. 178: 2610; author reply 2610-2611.
28. von Aulock, S., T. Hartung, and C. Hermann. 2007. Comment on "Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus". J. Immunol. 178: 2610, author reply 2610-2611.
29. Wu, P., and L. Brand. 1994. Resonance energy transfer: methods and applications. Anal. Biochem. 218: 1-13.
30. Kenworthy, A. K., andM. Edidin. 1998. Distribution of a glycosylphosphatidylinositol-anchored protein at the apical surface of MDCK cells examined at a resolution of <100 A using imaging fluorescence resonance energy transfer. J. Cell Biol. 142: 69-84.
31. Kenworthy, A. K., and M. Edidin. 1999. Imaging fluorescence resonance energy transfer as probe of membrane organization and molecular associations of GPI-anchored proteins. Methods Mol. Biol. 116: 37-49.
32. Deininger, S., S. Traub, D. Aichele, T. Rupp, T. Baris, H. M. Möller, T. Hartung, and S. von Aulock. 2008. Presentation of lipoteichoic acid potentiates its inflammatory activity. Immunobiology 213: 519-529.
33. Nilsen, N. J., S. Deininger, U. Nonstad, F. Skjeldal, H. Husebye, D. Rodionov, S. von Aulock, T. Hartung, E. Lien, O. Bakke, and T. Espevik. 2008. Cellular trafficking of lipoteichoic acid and Toll-like receptor 2 in relation to signaling: role of CD14 and CD36. J. Leukoc. Biol. 84: 280-291.
34. Triantafilou, M., M. Manukyan, A. Mackie, S. Morath, T. Hartung, H. Heine, and K. Triantafilou. 2004. Lipoteichoic acid and toll-like receptor 2 internalization and targeting to the Golgi are lipid raft-dependent. J. Biol. Chem. 279: 40882-40889.
35. Kalsi, J., C. T. Ravirajan, A. Rahman, and D. A. Isenberg. 1999. Structure-function analysis and the molecular origins of anti-DNA antibodies in systemic lupus erythematosus. Expert Rev. Mol. Med. 1999: 1-28.
36. Hermann, C., I. Spreitzer, N. W. Schröder, S. Morath, M. D. Lehner, W. Fischer, C. Schütt, R. R. Schumann, and T. Hartung. 2002. Cytokine induction by purified lipoteichoic acids from various bacterial species - role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-gamma release. Eur. J. Immunol. 32: 541-551.
37. Takeuchi, O., T. Kawai, P. F. Mühlradt, M. Morr, J. D. Radolf, A. Zychlinsky, K. Takeda, and S. Akira. 2001. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 13: 933-940.
38. Zähringer, U., B. Lindner, S. Inamura, H. Heine, and C. Alexander. 2008. TLR2-promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology 213: 205-224.
39. Markham, J. L., K. W. Knox, R. G. Schamschula, and A. J. Wicken. 1973. Antibodies to teichoic acids in man. Arch. Oral Biol. 18: 313-319.
40. Gargir, A., I. Ofek, D. Hasty, S. Meron-Sudai, H. Tsubery, Y. Keisari, and A. Nissim. 2001. Inhibition of antibody-dependent stimulation of lipoteichoic acid-treated human monocytes and macrophages by polyglycerolphosphate-reactive peptides. J. Leukoc. Biol. 70: 537-542.
41. Sutterwala, F. S., G. J. Noel, R. Clynes, and D. M. Mosser. 1997. Selective suppression of interleukin-12 induction after macrophage receptor ligation. J. Exp. Med. 185: 1977-1985.
42. Marth, T., and B. L. Kelsall. 1997. Regulation of interleukin-12 by complement receptor 3 signaling. J. Exp. Med. 185: 1987-1995.
43. Grazia Cappiello, M., F. S. Sutterwala, G. Trinchieri, D. M. Mosser, and X. Ma. 2001. Suppression of Il-12 transcription in macrophages following Fc gamma receptor ligation. J. Immunol. 166: 4498-4506.
44. Parcina, M., C. Wendt, F. Goetz, R. Zawatzky, U. Zähringer, K. Heeg, and I. Bekeredjian-Ding. 2008. Staphylococcus aureus-induced plasmacytoid dendritic cell activation is based on an IgG-mediated memory response. J. Immunol. 181: 3823-3833.
45. Levels, J. H., P. R. Abraham, E. P. van Barreveld, J. C. Meijers, and S. J. van Deventer. 2003. Distribution and kinetics of lipoprotein-bound lipoteichoic acid. Infect. Immun. 71: 3280-3284.
46. Grunfeld, C., M. Marshall, J. K. Shigenaga, A. H. Moser, P. Tobias, and K. R. Feingold. 1999. Lipoproteins inhibit macrophage activation by lipoteichoic acid. J. Lipid Res. 40: 245-252.
47. Mueller, M., C. Stamme, C. Draing, T. Hartung, U. Seydel, and A. B. Schromm. 2006. Cell activation of human macrophages by lipoteichoic acid is strongly attenuated by lipopolysaccharide-binding protein. J. Biol. Chem. 281: 31448-31456.
48. De Kimpe, S. J., M. Kengatharan, C. Thiemermann, and J. R. Vane. 1995. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc. Natl. Acad. Sci. USA 92: 10359-10363.
49. Bubeck Wardenburg, J., W. A. Williams, and D. Missiakas. 2006. Host defenses against Staphylococcus aureus infection require recognition of bacterial lipoproteins. Proc. Natl. Acad. Sci. USA 103: 13831-13836.